“The treatments won’t be covered by health insurance, “so it’s probably initially going to be a therapy for relatively well-off people who have these conditions,” Perkins says.”
Australia’s TGA will let authorized psychiatrists prescribe MDMA for PTSD and psilocybin for treatment-resistant depression from July 1. The same regulator rejected the idea in December 2021. It still hasn’t set training standards for prescribers, and the longest follow-up data covers 12 months. A world first that insurance won’t pay for is a world first for the rich.